Role of the functional MKK4 promoter variant in a decreased risk of prostate cancer: case-control study and meta-analysis
Journal of Cancer Research & Clinical Oncology, 05/09/2012
Evidence Based Medicine
Shao N et al. – The results suggest that the functional –1304G variant in the MKK4 promoter decreases the risk of prostate cancer by increasing the promoter activity.